Personalised medicine in exacerbations of COPD: the beginnings
Author:
- Sanjay SethiSSSanjay Sethi
- 30 November 2012
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 40 (6) , 1318-1319
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Blood Eosinophils to Direct Corticosteroid Treatment of Exacerbations of Chronic Obstructive Pulmonary Disease: A Randomized Placebo-Controlled TrialAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Moxifloxacinversusamoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL resultsEuropean Respiratory Journal, 2011
- Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Identification of Biologic Clusters and Their BiomarkersAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Antibiotic Therapy and Treatment Failure in Patients Hospitalized for Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseJAMA, 2010
- Infection in the Pathogenesis and Course of Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2008
- Inflammatory Profile of New Bacterial Strain Exacerbations of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2007
- Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary diseaseThorax, 2007
- Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trialThe Lancet, 2001
- Effect of Systemic Glucocorticoids on Exacerbations of Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 1999